NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
There are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furtherm...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2020-07-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://www.revistasad.com/index.php/diabetes/article/view/230 |
| _version_ | 1818316290436104192 |
|---|---|
| author | León Litwak |
| author_facet | León Litwak |
| author_sort | León Litwak |
| collection | DOAJ |
| description | There are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furthermore, carbohydrate (HD) count without adequate general dietary education, associated with intensified insulin therapy (IT), is nowadays linked to a higher incidence of hypoglycemia, obesity and other risk factors such as dyslipidemia (DSL), hypertension (HT), obesity (O) and abdominal obesity (OA) in this population, which generates a very frequent phenotype of patients with DM1 associated with metabolic syndrome (SM). |
| first_indexed | 2024-12-13T09:19:05Z |
| format | Article |
| id | doaj.art-928243f44f5b4094a1aebd53c2e3e8d0 |
| institution | Directory Open Access Journal |
| issn | 0325-5247 2346-9420 |
| language | Spanish |
| last_indexed | 2024-12-13T09:19:05Z |
| publishDate | 2020-07-01 |
| publisher | Sello Editorial Lugones |
| record_format | Article |
| series | Revista de la Sociedad Argentina de Diabetes |
| spelling | doaj.art-928243f44f5b4094a1aebd53c2e3e8d02022-12-21T23:52:47ZspaSello Editorial LugonesRevista de la Sociedad Argentina de Diabetes0325-52472346-94202020-07-01532Sup161610.47196/diab.v53i2Sup.230177NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)León Litwak0Hospital Italiano de Buenos Aires. Sociedad Argentina de Diabetes. Ciudad Autónoma de Buenos AiresThere are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furthermore, carbohydrate (HD) count without adequate general dietary education, associated with intensified insulin therapy (IT), is nowadays linked to a higher incidence of hypoglycemia, obesity and other risk factors such as dyslipidemia (DSL), hypertension (HT), obesity (O) and abdominal obesity (OA) in this population, which generates a very frequent phenotype of patients with DM1 associated with metabolic syndrome (SM).https://www.revistasad.com/index.php/diabetes/article/view/230fármacosdiabetes. |
| spellingShingle | León Litwak NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) Revista de la Sociedad Argentina de Diabetes fármacos diabetes. |
| title | NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) |
| title_full | NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) |
| title_fullStr | NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) |
| title_full_unstemmed | NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) |
| title_short | NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2) |
| title_sort | non insulin drugs in diabetes mellitus type 1 metformine idpp 4 pramlintida aglp 1 isglt 2 |
| topic | fármacos diabetes. |
| url | https://www.revistasad.com/index.php/diabetes/article/view/230 |
| work_keys_str_mv | AT leonlitwak noninsulindrugsindiabetesmellitustype1metformineidpp4pramlintidaaglp1isglt2 |